Sub menu

 
 

IRINOTECAN KABI irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Cancelled at the request of the sponsor

Product name
IRINOTECAN KABI irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Sponsor
Cancelled under Section 30(1)(c) of the Act
ARTG
171228
Date of effect
Decision type
Cancelled at the request of the sponsor

Help us improve the Therapeutic Goods Administration site